Stevanato Group S.p.A. (STVN)
NYSE: STVN · Real-Time Price · USD
23.66
-0.54 (-2.23%)
Aug 8, 2025, 3:36 PM - Market open
CTI BioPharma Revenue
Stevanato Group had revenue of 280.04M EUR in the quarter ending June 30, 2025, with 7.88% growth. This brings the company's revenue in the last twelve months to 1.15B, up 5.28% year-over-year. In the year 2024, Stevanato Group had annual revenue of 1.10B with 1.72% growth.
Revenue (ttm)
1.15B EUR
Revenue Growth
+5.28%
P/S Ratio
4.91
Revenue / Employee
207,407 EUR
Employees
5,521
Market Cap
6.46B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.10B | 18.68M | 1.72% |
| Dec 31, 2023 | 1.09B | 101.67M | 10.34% |
| Dec 31, 2022 | 983.68M | 139.76M | 16.56% |
| Dec 31, 2021 | 843.92M | 181.88M | 27.47% |
| Dec 31, 2020 | 662.04M | 125.50M | 23.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
STVN News
- 3 days ago - Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025 - Business Wire
- 16 days ago - Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S. - Business Wire
- 16 days ago - Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025 - Business Wire
- 17 days ago - Stevanato: Expansion In Italy And The U.S. Will Pave The Way - Seeking Alpha
- 6 weeks ago - Stevanato: Recovery Underway, Buy Confirmed - Seeking Alpha
- 3 months ago - Stevanato Group S.p.A. (STVN) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Stevanato Group to Participate in Upcoming Investor Conferences - Business Wire
- 3 months ago - Stevanato Group Reports Revenue of €256.6 Million for the First Quarter of 2025 - Business Wire